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The interaction of diphtheria toxin and its enzymatically deficient mutants crm 176 and crm 197 with lipos- 
omes has been studied by turbidity measurement and hydrophobic photolabelling with photoactivatable 
phosphatidylcholines. Diphtheria toxin and crm 176 at neutral pH bind to the surface of lipid bilayers while 
crm 197 also appears to interact with the fatty acid chains of phospholipids. All proteins undergo achange 
in conformation over the same range of acidic pH and become able to insert in the lipid bilayer. The tighter 
lipid interaction of crm 197 may account for its higher cell association constant. The possibility is discussed 
that the binding of diphtheria toxin to cells is mediated by both a protein receptor and an interaction with 
the head group of phospholipids. 
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1. INTRODUCTION 
Diphtheria toxin (DT) is the most studied 
member of a group of protein toxins that kill cells 
by blocking their protein synthesis [1]. 
The protein is secreted as a single inactive 
polypeptide chain of 58.342 kDa by pathogenic 
strains of Corynebacterium diphtheriae [2,3]. DT 
is activated by trypsin which cleaves the protein in- 
to two fragments: A, an ADP-ribosylase 
(21.164 kDa), and B (37.194 kDa) that is con- 
sidered to be responsible for binding of the toxin 
to sensitive cells [4,5]. 
Cell intoxication involves three main steps: 
binding, crossing of the membrane and target 
modification. Only the third point has been 
clarified at the molecular level: it is now known 
Correspondence address: C. Montecucco, Istituto di 
Patologia Generale, Via Loredan, 16, 35131 Padova, 
Italy 
that protein synthesis is blocked by specific ADP- 
ribosylation of elongation factor 2 that causes its 
detachment from ribosomes [6]. Despite numerous 
studies little is known about DT binding and 
translocation; an as yet unidentified receptor pro- 
tein is involved [7] and the toxin-receptor complex 
is thought to enter a coated pit and then an en- 
dosome [8,9]. There is strong evidence that the low 
pH of the vesicle lumen is sufficient o allow the 
toxin to translocate its enzymatic activity to the 
cytoplasm [10]. 
Several mutants of diphtheria toxin that cross- 
react immunologically with it (and hence are called 
crm) but are only partially toxic or completely non- 
toxic have been isolated. Among these mutants, 
crm 176 and crm 197 have been recently sequenced 
[11,12]. As shown in fig.l, they have a single 
amino acid replacement in the enzymic A chain. 
While crm 197 is totally inactive, crm 176 preserves 
part of its ADP-ribosylase activity, crm 197 shows 
very unusual cell association properties with a 
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Fig. 1. Schematic structure of diphtheria toxin showing 
its two-chain structure, position of disulfide bridges and 
the single amino acid substitutions present in the A chain 
of mutants crm 176 and crm 197. 
much higher binding constant to cells than the 
native DT [13]. It has also been proposed that this 
mutant should be used for a safer and simpler new 
vaccine against diphtheria [14]. 
Here we compare the interaction of DT, crm 176 
and crm 197 with liposomes by two sensitive 
techniques for monitoring lipid-protein interac- 
tiotts [~5,t6~. The presertt f}rzdirtgs provide ar~ ex- 
l~{atta¢iott for ~he membraae  bit ld ittg ~ro~er ty  o f  
c rm 197 and suggest hat, in addition to a protein, 
h'p/ds are also i nvo lved  in the associaffon o f  
diphtheria toxin to cells. 
2. EXPERIMENTAL 
2.1. Mater ia l s  
DT, crm 176 and crm 197 were prepared from 
strain as repor ted  by  Rappuoli et al. [17,18]. The 
toxins were nicked by trypsin treatment [19]. Pro- 
teins were dissolved in 10 mM sodium phosphate, 
125 mM NaCl (pH 7.2) at concentrations between 
1.4 and 9.6 mg/ml  and stored at -80~C.  
1 - Palmitoyl-2- (2- azido-4-nitrobenzoyl)-sn-gly- 
Ci/mmol) and 1-myristoyl-2-[12-amino(4-N-3- 
nitro - 1 - azidophenyl)]dodecanoyl -sn - glycero - 3 - 
[14C]phosphocholine (PC II, spec. act. 174 Ci/ 
mol) were prepared as described [20]. Dipal- 
mitoylphosphatidylcholine (DPPC), dipalmitoyl- 
phosphatidic acid (DPPA) and soybean asolectin 
were from Sigma. DPPC was purified by acetone 
trea~men't and asolec~in as des~ed earlier I21|. 
2.2. Methods  
Small unilamellar vesicles (SUV) of DPPC- 
DPPA (9:1, w/w) or asolectin were prepared by 
pulsed ultrasonic dispersion of lipid films in 125 
NaCl, 10 mM sodium phosphate, 10 mM sodium 
citrate, 1.5 mM EDTA, pH 7.4 (citrate-phosphate 
buffer) with a Branson B 30 sonifier under a 
nitrogen atmosphere for a total sonication time of
15 min. Undispersed lipids and particles were 
removed by 15 min centrifugation at 40000 x g. 
The lipid vesicles were used after overnight incuba- 
tion at 45°C for DPPC-DPPA and at 18°C for 
asolectin. 
Liposome turbidity was measured as the change 
in absorbance at 334 nm in an Eppendorf 
photometer equipped with a water thermostatted 
and stirred cuvette. 
Hydrophobic photolabelling and radioactivity 
determinations were performed as in [21] except 
for the use of a citrate-phosphate buffer instead of 
Tris-acetate. Electrophoresis was performed ac- 
cording to Laemmli [22] in 1507o polyacrylamide 
slab gels. 
' 
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Fig.2. Effect of crm 197 (A), DT (B) and crm 176 (C) or 
nothing (D) on the turbidity of SUV of DPPC-DPPA. 
The toxin (20/~g) was added to 2 ml of a stirred lipid 
suspension (200aM) in 125 mM NaCl, 10 mM Na- 
citrate, l0 mM NanPi, 1.5 mM EDTA, pH 7.4, 
thermostatted at 45°C. pH was lowered to 4.5 by 
addition of an appropriate amount of 8.5°7o phosphoric 
acid. Turbidity was determined as the absorbance 
change at 334 rim. 
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3. RESULTS 
The change in turbidity of phospholipid vesicles 
induced by a protein is a very sensitive parameter 
for monitoring the occurrence of lipid-protein in- 
teractions as has been shown for colicin A and 
diphtheria toxin [15,23]. Here we have used this 
assay to compare the effects of DT, crm 176 and 
crm 197 on liposomes. In most experiments SUV 
of DPPC-DPPA were used because they give very 
reproducible results, but similar findings were ob- 
tained with other liposomes containing negative 
lipids, for instance asolectin. 
Fig.2 shows that crm 197, more than DT and 
crm 176, induces a very small but significant 
change in turbidity implying that it causes a small 
crm 176 
change in dispersion state of the lipid vesicles. 
Different experimental approaches have in- 
dicated that at low pH DT becomes hydrophobic 
and inserts into the lipid bilayer [21,24-27]. As 
shown in fig.2, at pH 4.5 all toxins induce a very 
large change in turbidity that may be related to 
liposome aggregation and/or  fusion. That both 
phenomena occur is evident from electron 
micrographs of negatively stained preparations of 
liposomes incubated with the toxins at pH 5 (not 
shown). These results are closely related to those 
obtained by Cabiaux et al. [23]; however, we 
found that on SUV containing a negatively 
charged lipid such as DPPA, DT shows an effect 
several fold higher than that on liposomes of pure 
phosphatidylcholine. 
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Fig.3. Hydrophobic photolabelling of crm 176 (A,C) and crm 197 (B,D) with purified soybean liposomes tagged with 
both PC I (A,B) and PC II (C,D) at neutral pH (open symbols) and at pH 4.5 (closed symbols). The top panel shows 
the profile of the Coomassie blue-stained gel of the toxins before slicing and counting; note that the A fragments of 
crm 197 have a lower electrophoretic mobility in SDS than the corresponding polypeptide of crm 176 (and of DT). On 
the right-hand side the structural formulae of PC I and PC II are shown with respect to their corresponding patterns 
of labelling. The lipid front is not shown here because slicing was terminated shortly after the protein bands. 
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The extent of the turbidity change of SUV of 
DPPC-DPPA induced by DT, crm 176 and crm 
197 in all cases reaches a plateau in the range 
4.5-5.0; the pH values of half-maximal effect are 
reported in table 1. 
To gain more information on the interaction of 
the toxins with the lipid bilayer hydrophobic 
photolabelling experiments were performed with 
two photoactive phosphatidylcholines, whose for- 
mulae are shown on the right-hand side in fig.3. 
They probe membrane regions at different depths 
[28]. Once activated by illumination, PC I reacts 
with protein segments intercalated with the polar 
head groups of phospholipids while photoac- 
tivated PC II reacts with protein residues embed- 
ded in the hydrophobic ore of the membrane. 
Fig.3 shows the distribution of radioactivity 
associated with the two fragments of crm 176 and 
crm 197 after incubation with asolectin vesicles at 
neutral and low pH. The profile of labelling of DT 
(not shown) is almost superimposable on that of 
crm 176. While DT and crm 176 at nbutral pH are 
labelled only with the surface probe PC I, crm 197 
reacts with both phospholipid reagents. 
These findings indicate that DT and crm 176 in- 
teract at neutral pH with a negatively charged lipid 
bilayer and that this interaction is confined to the 
polar head group region. In addition to a surface 
interaction, crm 197 appears to expose part of its 
surface to the fatty acid chains of phospholipids 
and both fragments of crm 197 are involved in this 
interaction. However, we do not know whether the 
PC II labelling of crm 197 at neutral pH cor- 
responds to its actual penetration in the 
Table 1 
pH values at which 50% of the maximal effects of DT 
and mutants on the change in turbidity of DPPC-DPPA 
SUV and on the hydrophobic photolabelling with 
photoreactive phosphatidylcholines arefound 
Fragments Turbidity Hydrophobic photolabelling 
(A-B) 
PC I PC II 
A B A B 
DT 5.8 5.3 5.8 5.3 5.8 
crm 176 5.8 5.2 5.7 5.2 5.7 
crm 197 5.9 5.4 5.7 5.4 5.8 
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Fig.4. A schematic drawing illustrating the different 
lipid interaction of DT and crm 197 which may explain 
the different strength of interaction shown by these two 
proteins with the plasma membrane. The toxin is shown 
to bind to lipids first and then to move laterally with 
lipids to encounter a protein receptor to take into 
account different amount of cell surface occupied by 
lipids and by the protein receptor. 
hydrophobic ore of the lipid bilayer or if it per- 
turbs the bilayer architecture in such a way as to 
bring the fatty acid methyl terminus closer to the 
bilayer surface. Whatever the reason for the dif- 
ferent crm 197 labelling, this finding indicates that 
an alteration in the A chain can be transmitted to 
the B chain in such a way as to influence the mem- 
brane interaction of this mutant toxin. 
It has been previously shown that at low pH DT 
becomes hydrophobic and penetrates the lipid 
bilayer in a process involving both fragments 
[21,25,26]. Also, crm 176 and crm 197 are able to 
undergo this low pH-induced conformational 
change and to enter into contact with the hydrocar- 
bon chains of phospholipids as shown in fig.3. 
Table 1 reports the pH of the half-maximal effect 
for both the turbidity and hydrophobic 
photolabelling experiments. These values fall 
within the physiological pH range since they have 
been actually shown to be reached in endosomes in
vivo [29]. 
The close similarity of the patterns obtained 
with the surface (PC I) and deeper (PC II) probes 
strongly suggests that DT, crm 176 and crm 197 at 
low pH become true integral proteins of the mem- 
brane with both their fragments exposing part of 
their surface to lipids. This is a necessary step in 
the membrane-crossing process which has been 
shown to require a pH gradient across the mem- 
brane to be accomplished [30]. 
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4. DISCUSSION 
The different membrane interaction of crm 197 
with respect to DT and crm 176 that appears to in- 
volve both fragments A and B was rather unex- 
pected on the basis of a single amino acid 
substitution, Glu for Gly residue at position 52 of 
the A chain [11]. That this single replacement is
sufficient o cause a relevant structural difference 
between crm 197 and DT is also suggested by its 
higher trypsin sensitivity, and different CD spec- 
trum [13,31] and mobility of the A chain in SDS- 
PAGE (cf. top panels of fig.3). The present 
findings suggest hat an altered conformation of 
the A chain of DT can affect the structure of the 
B chain. This conclusion is supported by the dif- 
ferent affinity of two B chain-specific monoclonal 
antibodies vs crm 197 and DT (Bigio, M., Rap- 
puoli, R. and Ratti, G., in preparation). The pre- 
sent data provide further support in favour of 
Lory et al. [32] who suggested that the two chains 
of DT are closely associated and do not form 
separate domains. Moreover, if Gly 52 is a part of 
the NAD+-binding site as suggested by its 
relevance for the enzymic activity of DT, these 
data would also agree with the idea that the 
NAD+-binding site of DT is in a cleft between the 
two toxin fragments [32]. 
On the basis of the present results and of a 
model recently put forward to account for the 
membrane binding properties of tetanus and 
botulinum toxins [33], we can advance an explana- 
tion for the higher cell association constant of crm 
197 with respect o DT [13]. As depicted in fig.4, 
DT is suggested to bind to the cell surface not sole- 
ly via a protein receptor but also through an in- 
teraction with the polar head group of negatively 
charged phospholipids. Hence, its cell binding con- 
stant is the product of the two single binding con- 
stants: that for lipids and that for the protein 
receptor. This mode of binding can account for 
strong association of toxin to a sensitive cell even 
in the absence of a specific DT receptor. Such 
toxin-specific receptors are unlikely to exist 
because their presence would improve the efficien- 
cy of cell killing. Therefore, it may be assumed 
that there has been no evolutionary pressure to in- 
crease the cell ability to bind toxins; rather, it is 
believed that the toxin parasitizes a plasma mem- 
brane protein of as yet unknown function. 
It should also be noted that binding of the toxin 
to lipid leads to an effective increase in its concen- 
tration on the membrane and hence to a much 
higher concentration of toxin-receptor complexes 
thus leading to a high efficiency of intoxication. 
Moreover, lipid binding can change the conforma- 
tion of DT and hence its affinity for the protein 
receptor as suggested for the binding of tetanus 
and botulinum neurotoxins to polysialoganglio- 
sides [33]. 
The interaction of crm 197 with the 
phospholipid fatty acid chains, found here, is ex- 
pected to confer additional strength on its binding 
to the lipid bilayer with respect o DT as shown in 
fig.4. This difference could well account for its 
stronger binding to cells reported in [13]. If this is 
the case the suggested purification of the DT recep- 
tor by affinity chromatography on a crm 197 col- 
umn [13] may turn out to be unsuccessful. 
The unspecific binding of DT to negative lipids 
may be relevant o its killing of insensitive cells 
which occurs in the micromolar ange instead of 
the nanomolar range in the case of sensitive cells: 
it corresponds to a concentration step of the toxin 
on the membrane thus increasing its probability of 
being endocytosed even in the absence of a recep- 
tor protein present on sensitive cells. 
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